Sandra Haberthuer

Long-chain formoterol analogues: an investigation into the effect of increasing amino-substituent chain length on the beta2-adrenoceptor activity.

B. Cuenoud, David Beer, P. Gedeck, 2004, Bioorganic & medicinal chemistry letters.

A solid-phase approach towards the synthesis of PDE5 inhibitors.

David Beer, H. Moser, A. Dunstan, 2002, Bioorganic & medicinal chemistry letters.

Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate.

J. Fozard, T. Keller, David Beer, 2012, Journal of medicinal chemistry.

Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate esters.

J. Fozard, Deborah Hynx, Keith Butler, 2004, Bioorganic & medicinal chemistry.

8-Aryl xanthines potent inhibitors of phosphodiesterase 5.

Stephen P. Jelfs, M. Zurini, R. Naef, 2002, Bioorganic & medicinal chemistry letters.

A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential.

J. Fozard, T. Keller, N. Press, 2005, Bioorganic & medicinal chemistry letters.

Potent and selective xanthine-based inhibitors of phosphodiesterase 5.

M. Zurini, R. Naef, S. Watson, 2007, Bioorganic & medicinal chemistry letters.

Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).

T. Keller, David Beer, N. Press, 2015, Journal of medicinal chemistry.